Wenying Peng
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Acquired EGFR L858R mutation following ALK-TKI resistance in lung adenocarcinoma: a case report.
Journal: Frontiers in oncology
Published: January 03, 2026
Analysis of germline-somatic mutational connections in colorectal cancer reveals differential tumorigenic patterns and a novel predictive marker for germline mutation carriers.
Journal: Cancer letters
Published: October 20, 2024
A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score.
Journal: MedComm
Published: July 19, 2023
Advances in immune checkpoint inhibitors induced-cardiotoxicity.
Journal: Frontiers in immunology
Published: December 23, 2022
Stratification of non-small cell lung adenocarcinoma patients with EGFR actionable mutations based on drug-resistant stem cell genes.
Journal: iScience
Published: September 28, 2022
Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma.
Journal: Frontiers in oncology
Published: July 03, 2022
CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types.
Journal: Frontiers in immunology
Published: June 21, 2022
Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Journal: The oncologist
Published: July 11, 2021
Research Progress of Anti-angiogenic Agents Combined with Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 05, 2021
Case Report: Therapeutic Response to Chemo-Immunotherapy in an Advanced Large Cell Lung Carcinoma Patient With Low Values of Multiple Predictive Biomarkers.
Journal: Frontiers in immunology
Published: September 17, 2020
Dacomitinib induces objective responses in metastatic brain lesions of patients with EGFR-mutant non-small-cell lung cancer: A brief report.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 01, 2020
Last Updated: 09/26/2026